CoChat

Regulation of nuclear epigenome by mitochondrial DNA heteroplasmy

Open access

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Diseases associated with mitochondrial DNA (mtDNA) mutations are highly variable in phenotype, in large part because of differences in the percentage of normal and mutant mtDNAs (heteroplasmy) present within the cell. For example, increasing heteroplasmy levels of the mtDNA tRNA Leu(UUR) nucleotide (nt) 3243A > G mutation result successively in diabetes, neuromuscular degenerative disease, and perinatal lethality. These phenotypes are associated with differences in mitochondrial function and nuclear DNA (nDNA) gene expression, which are recapitulated in cybrid cell lines with different percentages of m.3243G mutant mtDNAs. Using metabolic tracing, histone mass spectrometry, and NADH fluorescence lifetime imaging microscopy in these cells, we now show that increasing levels of this single mtDNA mutation cause profound changes in the nuclear epigenome. At high heteroplasmy, mitochondrially derived acetyl-CoA levels decrease causing decreased histone H4 acetylation, with glutamine-derived acetyl-CoA compensating when glucose-derived acetyl-CoA is limiting. In contrast, α-ketoglutarate levels increase at midlevel heteroplasmy and are inversely correlated with histone H3 methylation. Inhibition of mitochondrial protein synthesis induces acetylation and methylation changes, and restoration of mitochondrial function reverses these effects. mtDNA heteroplasmy also affects mitochondrial NAD + /NADH ratio, which correlates with nuclear histone acetylation, whereas nuclear NAD + /NADH ratio correlates with changes in nDNA and mtDNA transcription. Thus, mutations in the mtDNA cause distinct metabolic and epigenomic changes at different heteroplasmy levels, potentially explaining transcriptional and phenotypic variability of mitochondrial disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1906896116

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. MtDNA heteroplasmy modulates metabolites and histone modifications. (A) Seven mtDNA m.3243A > G heteroplasmic cell lines plus the ρ0 parent cells were cultured in parallel for metabolite (j = 15) and histone modification (i = 107) quantification by liquid chromatography tandem mass spectrometry. Spearman correlation coefficient was calculated for each histone modification (unmod = unmodified peptide) against each metabolite (blue = positive, red = negative, and blank = no correlation), with the color intensity corresponding to correlation strength (significance = P < 0.05). (Example #1, blue box) Positive association between acetyl-CoA levels and histone H4 acetylation of lysines 8 (K8) and 16 (K16) across heteroplasmy levels. (Example #2, red box) Negative association between αKG/succinate ratio and histone H3 lysine 9 di- (me2) and trimethylation (me3) across heteroplasmy levels. Each point represents a measurement and lines represent local regression of the mean (R-software loess), n = 3. (B) Heat map of histone acetylation modifications of 0% and 100% m.3243G lines (n = 3), showing a dramatic effect of mtDNA genotype on the histone epigenome. (C) List of top 20 histone modifications ranked by P value, showing the strong effect on mtDNA genotype on H4K5, K8, K12, and K16 acetylation (n = 3). Although it can be argued that modification level changes at a particular site are not independent of either other changes at that site or overall changes in the associated peptide, we also include P values with an arbitrary correction factor, allowing a false discovery rate of 1% (adjusted P value).
Fig. 1. MtDNA heteroplasmy modulates metabolites and histone modifications. (A) Seven mtDNA m.3243A > G heteroplasmic cell lines plus the ρ0 parent cells were cultured in parallel for metabolite (j = 15) and histone modification (i = 107) quantification by liquid chromatography tandem mass spectrometry. Spearman correlation coefficient was calculated for each histone modification (unmod = unmodified peptide) against each metabolite (blue = positive, red = negative, and blank = no correlation), with the color intensity corresponding to correlation strength (significance = P < 0.05). (Example #1, blue box) Positive association between acetyl-CoA levels and histone H4 acetylation of lysines 8 (K8) and 16 (K16) across heteroplasmy levels. (Example #2, red box) Negative association between αKG/succinate ratio and histone H3 lysine 9 di- (me2) and trimethylation (me3) across heteroplasmy levels. Each point represents a measurement and lines represent local regression of the mean (R-software loess), n = 3. (B) Heat map of histone acetylation modifications of 0% and 100% m.3243G lines (n = 3), showing a dramatic effect of mtDNA genotype on the histone epigenome. (C) List of top 20 histone modifications ranked by P value, showing the strong effect on mtDNA genotype on H4K5, K8, K12, and K16 acetylation (n = 3). Although it can be argued that modification level changes at a particular site are not independent of either other changes at that site or overall changes in the associated peptide, we also include P values with an arbitrary correction factor, allowing a false discovery rate of 1% (adjusted P value).CC BY-NC-ND · PubMed Central
Fig. 2. Mitochondria as key supplier of epigenetic metabolites. (A) Mitochondrial metabolism of 13C glucose to produce nuclear/cytosolic acetyl-CoA. (B) Conversion of 13C-glucose into acetyl-CoA in 0% (0) and 100% (100) m.3243G cells and in 0% cells treated with CP (0+CP) without or with CP washout. (C) Steady-state (total) histone 4 acetylation (bar height) and 13C-glucose H4 acetylation (orange shading) in 0% and 100% heteroplasmy cells and 0% cells with CP. (D) Effect of CP and rotenone (Rot) on complex I, the TCA cycle, αKG levels, and histone JmjC demethylation. (E) Conversion of 13C-glucose to αKG, using the same labeling protocols as B). (F) Steady-state (total) histone 3 lysine 9 trimethylation, using the protocols of B). (G) 13C-glucose incorporation into acetyl-CoA in 0% mutant cells, without and with rotenone (Rot) inhibition. (H) Steady-state (total) (bar height) and 13C-glucose derived (orange bar) H4 acetylation without and with Rot inhibition. (I) 13C-glutamine incorporation into acetyl-CoA without and with Rot inhibition. (J) 13C-glutamine incorporation into H4 acetylation without and with Rot inhibition. (K) Conversion of 13C-glucose into αKG without and with Rot inhibition. (L) H3K9 di- and trimethylation (Left) and poly/monomethylation ratio (Right) of 0% cells without and with Rot inhibition. (M) Mitochondrial NAD+/NADH ratio determined by NADH lifetime in 0% cells without and with Rot inhibition; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant; n = 3.
Fig. 2. Mitochondria as key supplier of epigenetic metabolites. (A) Mitochondrial metabolism of 13C glucose to produce nuclear/cytosolic acetyl-CoA. (B) Conversion of 13C-glucose into acetyl-CoA in 0% (0) and 100% (100) m.3243G cells and in 0% cells treated with CP (0+CP) without or with CP washout. (C) Steady-state (total) histone 4 acetylation (bar height) and 13C-glucose H4 acetylation (orange shading) in 0% and 100% heteroplasmy cells and 0% cells with CP. (D) Effect of CP and rotenone (Rot) on complex I, the TCA cycle, αKG levels, and histone JmjC demethylation. (E) Conversion of 13C-glucose to αKG, using the same labeling protocols as B). (F) Steady-state (total) histone 3 lysine 9 trimethylation, using the protocols of B). (G) 13C-glucose incorporation into acetyl-CoA in 0% mutant cells, without and with rotenone (Rot) inhibition. (H) Steady-state (total) (bar height) and 13C-glucose derived (orange bar) H4 acetylation without and with Rot inhibition. (I) 13C-glutamine incorporation into acetyl-CoA without and with Rot inhibition. (J) 13C-glutamine incorporation into H4 acetylation without and with Rot inhibition. (K) Conversion of 13C-glucose into αKG without and with Rot inhibition. (L) H3K9 di- and trimethylation (Left) and poly/monomethylation ratio (Right) of 0% cells without and with Rot inhibition. (M) Mitochondrial NAD+/NADH ratio determined by NADH lifetime in 0% cells without and with Rot inhibition; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant; n = 3.CC BY-NC-ND · PubMed Central
Fig. 3. Mitochondrial NADH lifetime regulates glucose incorporation into acetyl-CoA and histone 4 lysine 16 acetylation. (A) Pseudocolored images mitochondrial NADH lifetime analysis using FLIM across cybrid heteroplasmy levels. (B) Quantification of mitochondrial NADH lifetimes (NAD+/NADH ratios) across cybrid heteroplasmy levels. (C) Conversion of 13C-glucose into acetyl-CoA across cybrid heteroplasmy levels. (D) 13C-glucose incorporation into H4K6 acetylation across cybrid heteroplasmy levels. (E) Relationship between NADH lifetime (NAD+/NADH) and 13C-glucose conversion to acetyl-CoA and H4K16 acetylation, showing strong correlation across cybrid heteroplasmy levels (Spearman), n = 3.
Fig. 3. Mitochondrial NADH lifetime regulates glucose incorporation into acetyl-CoA and histone 4 lysine 16 acetylation. (A) Pseudocolored images mitochondrial NADH lifetime analysis using FLIM across cybrid heteroplasmy levels. (B) Quantification of mitochondrial NADH lifetimes (NAD+/NADH ratios) across cybrid heteroplasmy levels. (C) Conversion of 13C-glucose into acetyl-CoA across cybrid heteroplasmy levels. (D) 13C-glucose incorporation into H4K6 acetylation across cybrid heteroplasmy levels. (E) Relationship between NADH lifetime (NAD+/NADH) and 13C-glucose conversion to acetyl-CoA and H4K16 acetylation, showing strong correlation across cybrid heteroplasmy levels (Spearman), n = 3.CC BY-NC-ND · PubMed Central
Fig. 4. Nuclear NADH lifetime correlates with mtDNA transcription and NAD+ biosynthesis gene induction. (A) Pseudocolored images mitochondrial NADH lifetime analysis using FLIM across cybrid heteroplasmy levels. (B) Quantification of nuclear NADH lifetimes (NAD+/NADH ratio) across cybrid heteroplasmy levels. (C) mRNA levels of key NAD+ de novo synthesis enzymes across cybrid heteroplasmy levels (AFMID, Arylformamidase; NADSYN1, NAD Synthetase 1 [rate-limiting]; HAAO, 3-hydroxyanthranilate 3,4-dioxygenase NMNAT1, Nicotinamide Nucleotide Adenylyltransferase 1). (D) mtDNA mRNA levels across cybrid heteroplasmy levels. Reproduced from ref. 7. (E) Parallel fluctuations of Nuclear NADH lifetime (black, left axis), normalized NADH synthesis mRNA levels (blue), and normalized mtDNA mRNA levels (red) across cybrid heteroplasmy levels; n = 3.
Fig. 4. Nuclear NADH lifetime correlates with mtDNA transcription and NAD+ biosynthesis gene induction. (A) Pseudocolored images mitochondrial NADH lifetime analysis using FLIM across cybrid heteroplasmy levels. (B) Quantification of nuclear NADH lifetimes (NAD+/NADH ratio) across cybrid heteroplasmy levels. (C) mRNA levels of key NAD+ de novo synthesis enzymes across cybrid heteroplasmy levels (AFMID, Arylformamidase; NADSYN1, NAD Synthetase 1 [rate-limiting]; HAAO, 3-hydroxyanthranilate 3,4-dioxygenase NMNAT1, Nicotinamide Nucleotide Adenylyltransferase 1). (D) mtDNA mRNA levels across cybrid heteroplasmy levels. Reproduced from ref. 7. (E) Parallel fluctuations of Nuclear NADH lifetime (black, left axis), normalized NADH synthesis mRNA levels (blue), and normalized mtDNA mRNA levels (red) across cybrid heteroplasmy levels; n = 3.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 159

Metadata

Authors
Kopinski, P. K., Janssen, K. A., Schaefer, P. M., Trefely, S., Perry, C. E., Potluri, P., Tintos-Hernandez, J. A., Singh, L. N., Karch, K. R., Campbell, S. L., Doan, M. T., Jiang, H., Nissim, I., Nakamaru-Ogiso, E., Wellen, K. E., Snyder, N. W., Garcia, B. A., & Wallace, D. C.
Affiliations
  • Children's Hospital of Philadelphia (US)
  • University of Pennsylvania (US)
  • Drexel University (US)
  • Center for Mitochondrial and Epigenomic Medicine, Children’s Hospital of Philadelphia, Philadelphia, PA 19104;
  • Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104;
Corresponding author
Wallace, Douglas C.
Venue
Proceedings of the National Academy of Sciences
Published
2019-06-28
Volume
116
Issue
32
Pages
16028-16035
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2955398568
Cited by
159
References
31
Citations by year
2026: 10 · 2025: 24 · 2024: 22 · 2023: 18 · 2022: 23 · 2021: 28 · 2020: 26 · 2019: 8
FWCI
7.03
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute (Predoctoral Grant)
  • HHS | NIH | National Institute of Neurological Disorders and Stroke (NS021328)
  • HHS | NIH | National Institute of Mental Health (MH108592)
  • HHS | NIH | National Institute of General Medical Sciences (OD010944)
  • DOD | United States Army | MEDCOM | Academy of Health Sciences (W81XWH-16-1-0401)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
mitochondrial heteroplasmy, m.3243A>G mutation, mitochondrial disease, histone H4 acetylation, histone H3 methylation, acetyl-CoA metabolism, alpha-ketoglutarate, NAD+/NADH ratio, mitochondrial translation, cybrid cells, mtDNA transcription, metabolic tracing
MeSH terms
Epigenome, Acetyl Coenzyme A, Cell Line, Cell Nucleus, DNA, Mitochondrial, Histones, Humans, Mitochondria, NAD, Transcription, Genetic, Metabolome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulation of nuclear epigenome by mitochondrial DNA heteroplasmy. https://app.cochat.ai/papers/10.1073/pnas.1906896116
The paper
Kopinski, P. K., Janssen, K. A., Schaefer, P. M., Trefely, S., Perry, C. E., Potluri, P., Tintos-Hernandez, J. A., Singh, L. N., Karch, K. R., Campbell, S. L., Doan, M. T., Jiang, H., Nissim, I., Nakamaru-Ogiso, E., Wellen, K. E., Snyder, N. W., Garcia, B. A., & Wallace, D. C. (2019). Regulation of nuclear epigenome by mitochondrial DNA heteroplasmy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1906896116

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.